Table 1 Demographic data for n= 1300 ALS subjects from the PRO-ACT database considered for analysis
Categorical Counts | |||
Sex | Male: 812 (63%) | Female: 488 (37%) | |
Race | White: 1218 (94%) | Black: 22 (2%) | Latino: 13 (1%) |
Asian: 12 (1%) | Indian: 1 (< 1%) | Other: 34 (3%) | |
Riluzole Use | Yes: 600 (46%) | No: 358 (28%) | Not Reported: 342 (26%) |
Continuous | Mean | SD | |
Age (at trial start) | 55.5 | 11.9 | |
Self-Reported Disease Onset Time (days from trial start) | − 658.4 | 456 | |
Number of ALSFRS scores | 9.3 | 4.5 | |